Saudi Journal of Medicine and Medical Sciences

ORIGINAL ARTICLE
Year
: 2016  |  Volume : 4  |  Issue : 3  |  Page : 202--205

Low bone mass secondary to antipsychotic medications


Abdallah S Al-Omran1, Mahdi S Abu-Madini2, Mir Sadat-Ali1, Moaad H Alfaraidy1, Waleed K Shihada2 
1 Department of Orthopaedic Surgery, College of Medicine, University of Dammam, King Fahd Hospital of the University, Al Khobar, Saudi Arabia
2 Department of Psychiatry, College of Medicine, University of Dammam, King Fahd Hospital of the University, Al Khobar, Saudi Arabia

Correspondence Address:
Mir Sadat-Ali
Department of Orthopaedic Surgery, College of Medicine, University of Dammam, King Fahd Hospital of the University, P.O. Box 40071, Al-Khobar 31952
Saudi Arabia

Background and Objective: Antipsychotic medications are known to cause low bone mass. The objective of this study was to assess the prevalence of osteopenia and osteoporosis secondary to patients taking antipsychotic medications. Patients and Methods: This prospective study included 175 patients taking antipsychotic medications and attending the psychiatric clinics at the King Fahd Hospital of the University, Al-Khobar, Saudi Arabia. Demographic data, antipsychotic medications, type, and duration of administration of medication were collected. All patients had bone mass measurement using dual energy X-ray (DXA) absorptiometry. Patients were divided into 5-year groups, from ≤35 to ≥51 years. The data were entered in the database and analyzed using SPSS Inc version 20. Results: The average age of patients was 40.75 ± 7.16 years (range: 26–56 years), there were 120 (82.8%) males and 25 (17.2%) females. Our results indicate that the average duration of anti-psychotic medication use was 8.45 ± 5.4 years. DXA of the hip revealed that 25 (14.2%) patients were osteoporotic and 104 (59.42%) were osteopenic, while on the basis of the T-score of the lumbar spine, 77 (44%) patients were osteoporotic and 80 (45.7%) were osteopenic. On the basis of the spinal bone mineral density (BMD), 89.7% had low bone mass. Conclusion: Anti-psychotic medications have a strong influence on the reduction of bone mass even in younger populations. The BMD of patients who are prescribed anti-psychotic medication need to be monitored for low bone mass and provided with the appropriate treatment.


How to cite this article:
Al-Omran AS, Abu-Madini MS, Sadat-Ali M, Alfaraidy MH, Shihada WK. Low bone mass secondary to antipsychotic medications.Saudi J Med Med Sci 2016;4:202-205


How to cite this URL:
Al-Omran AS, Abu-Madini MS, Sadat-Ali M, Alfaraidy MH, Shihada WK. Low bone mass secondary to antipsychotic medications. Saudi J Med Med Sci [serial online] 2016 [cited 2020 Sep 25 ];4:202-205
Available from: http://www.sjmms.net/article.asp?issn=1658-631X;year=2016;volume=4;issue=3;spage=202;epage=205;aulast=Al-Omran;type=0